Lucretia Sonderer Maas, FNP

Lucretia Maas practices at Sutter Imaging Roseville II in Roseville, California.

Lucretia Maas' NPI, 1891943502, was assigned on September 5, 2008. Lucretia Maas holds California license 18322.

Lucretia Maas' primary practice is Sutter Imaging Roseville II, at 2 Medical Plaza Ste 105, Roseville, CA 95661. The practice phone is (916) 865-1469.

Lucretia Maas' primary practice is Sutter Imaging Roseville II in Roseville, California. Lucretia Maas is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is SGMF Radiology. Dmand AI also links Lucretia Maas to 1 more group practice or clinic and 1 medical group, each named with a free account. Lucretia Maas' employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Lucretia Maas practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Lucretia Maas' primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Lucretia Maas is licensed in California.

CMS data shows 44 Medicare services from Lucretia Maas across 2 procedure codes in 2024, all of them office visits, for 44 Medicare patients. Medicare paid $3,094 for them. Every service was in an office.

CMS counts 44 Medicare patients who saw Lucretia Maas in 2024. The largest group is 65 to 74, with 16 patients. 66% of them have high blood pressure, and 64% have high cholesterol. 34% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Lucretia Maas' median patient age at 49, with 76% women.

In 2024, Lucretia Maas wrote 193 Medicare Part D claims for 69 patients. 81% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $185 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Lucretia Maas for performance year 2024, reported as part of a group. Lucretia Maas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lucretia Maas as offering telehealth.

CMS Open Payments shows 2 general payments to Lucretia Maas from 2 drug and device companies in 2024. Food and beverage make up the largest share, 100% of the total. Alnylam Pharmaceuticals Inc. paid the most, $122.